Skip to content
CityAM
Main navigation
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • Canada BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      Nationwide fires starting gun on mortgage deals ahead of interest rate decision

      Nationwide coverage map displaying regions affected by recent events, highlighting key areas of interest for general updates

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
    • From our partners
      • The Morning Briefing: SBS x CityAM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Children as young as 14 are being targeted by unregulated gambling firms on social media

      Unfortunately, without additional context from the article or details about what the image depicts, it is challenging to g...

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      Old Pulteney releases 50-year-old whisky for 200th anniversary

      Old Pulteney 50-Year-Old single malt Scotch whisky bottle with elegant packaging on display, highlighting luxury and craft...

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Latest Paper

Astrazeneca

  • Astra Zeneca revenues jump over 40 per cent amid vaccine rollout

    February 10, 2022

    Revenues at Astra Zeneca have risen 41 per cent, with Covid-19 vaccine sales boosting its performance across the year.

  • Pfizer accused of funding anti-AstraZeneca information

    December 5, 2021

    US drugmaker Pfizer, the world’s dominant Covid vaccine maker, has been accused of funding educational presentations that said its UK rival AstraZeneca was ineffective and even dangerous for some members of the population. A Channel 4 Dispatches investigation due to be broadcast this week says it has “uncovered evidence” that Pfizer funded a number of [...]

  • UK scientists discover what causes blood clot complications in AstraZeneca Covid vaccine

    December 2, 2021

    UK scientists believe they have found the reason behind the extremely rare blood clot complications stemming from the Oxford/AstraZeneca vaccine. According to an international team of researchers from Cardiff and the US, the reaction can be traced to the way the adenovirus used by the vaccine to shuttle the coronavirus’ genetic material into cells binds [...]

  • ‘Don’t freak out’: Vaccine bosses attempt to diffuse Omicron-induced jab fears 

    November 30, 2021

    Vaccine leaders have rushed to put out the fires of Moderna CEO’s jab cautions, urging the world: “Don’t freak out”.  Pharmaceutical heavyweights have been gathering data on the latest Covid-19 variant Omicron, as concerns swell that a tailor-made vaccine may be necessary. AstraZeneca is already researching locations where the variant has been identified, namely in [...]

  • AstraZeneca opens new £1bn research fortress in Cambridge for army of 2,200 scientists

    November 25, 2021

    AstraZeneca has officially opened The Discovery Centre (DISC) in Cambridge, its newest research and development facility which will swing open its doors to 2,200 research scientists from today. The new £1bn facility will include robotics, high-throughput screening and AI-driven technology. It will support AstraZeneca’s focus on specialised and precision medicines and foster the discovery and [...]

  • Covid-19 global pandemic to be ‘regional epidemic’ by next year, says AstraZeneca boss

    November 23, 2021

    AstraZeneca boss Pascal Soriot said that he expects the global Covid-19 pandemic to become a regional epidemic by next year, after the pharmaceutical giant decided to start profiting from its vaccine. The chief executive of the pharmaceutical giant told Sky News that by 2022, “essentially most of the world at that point will be in [...]

  • AstraZeneca sales jump 50 per cent as vaccine crawls to profitability

    November 12, 2021

    AstraZeneca’s revenues have soared 32 per cent this year to $25.4bn, powered by booming product sales. Third quarter revenues are up 50 per cent, with the pharmaceutical giant enjoying a $9.87 billion increase in revenues over the three-month period. The company has sold 2.2 billion vaccines since the start of the year. It has now [...]

  • AstraZeneca says new Coronavirus antibody treatment can prevent as well as cure Covid-19

    October 11, 2021

    AstraZeneca said in a filing this morning that a new antibody treatment the British pharma giant has developed has the ability to prevent as well as treat Covid-19. The company has filed a request to the US Food and Drug Administration (FDA) last week for emergency use authorisation for AZD7442, which is made up of [...]

  • Oxford-AstraZeneca vaccine creator to make keynote speech at UK’s Global Investment Summit

    October 11, 2021

    The UK’s pharmaceutical industry is set to take top billing at the UK’s Global Investment Summit next week, with GlaxoSmithKline’s chief executive and one of the creator’s of the Oxford-AstraZeneca vaccine to deliver keynote speeches. GSK chief Dame Emma Walmsley and Oxford University vaccinologist Sarah Gilbert will be alongside World Trade Organisation (WTO) director-general Dr [...]

  • Your third Covid shot is coming: All you need to know about booster vaccines

    October 3, 2021

    It seems inevitable: a third Covid shot is coming your way this Autumn. Two jabs may not give us sufficient protection, or at least not in the long term. Booster jabs are being offered as part of a ramped-up vaccine campaign in England. Some 1.5 million people will be contacted and encouraged to use the [...]

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • …
  • Page 27
  • Next

Trending Articles

  • As it happened: FTSE 100 relief rally runs out of steam as BP and Shell weigh; Oil hits three-month low

  • London Tech Week sums up everything wrong with UK tech

  • Rolls-Royce shares surge as SMR unit bags multi-billion pound Swedish nuclear contract

  • Rathbones to suspend thousands of client account inflows after FCA probe deals £530m blow

  • KPMG’s Summer Friday half-day rollback signals deeper woes for Big Four giants

  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • News
  • Markets & Economics
  • Politics
  • Opinion
  • Life&Style
  • Personal Finance

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
Copyright 2026 CityAM Limited